UPSC 2023 · GS 3
Faster economic growth requires increased share of the manufacturing sector in GDP, particularly of MSMEs. Comment on the present policies of the Government in this regard.
Read this PYQ →GS 3 · Industrial policy and supply chains
Semicon India 2026 and India's Growing Semiconductor Ecosystem
Published · Updated
At the inauguration of SEMICON India 2026, the Prime Minister highlighted the rapid expansion of India's semiconductor ecosystem, emphasizing new avenues for high-tech investment, domestic innovation, and strategic manufacturing partnerships.
WHY THIS MATTERS FOR MAINS
Examine the challenges and prospects: move beyond the headline.
For GS 3, the explicit demand is to examine how semiconductor policy can build a viable manufacturing ecosystem and where implementation falls short. The implicit demand is to connect incentives with skills, infrastructure and technology access, then weigh strategic resilience against fiscal and environmental costs. A balanced answer distinguishes announcements and investment commitments from operational capacity.
Study angle, not an exam prediction · GS 3 / Economy & agriculture
Background and Policy Context
- India's semiconductor push is anchored by targeted fiscal incentives and design-linked incentive schemes to reduce import dependency.
- The establishment of fabrication plants and packaging units across states marks a shift from assembly to core manufacturing.
- SEMICON India serves as a crucial convening platform for global technology leaders, startups, and policymakers.
Strategic Significance and Supply Chains
- Developing a robust domestic semiconductor base enhances strategic autonomy in critical technology sectors.
- Integration into global supply chains helps diversify manufacturing hubs away from traditional geographic concentrations.
- The ecosystem generates high-value employment for engineering graduates and fosters a deep tech research culture.
Implementation Challenges
- Complexities in securing continuous supply of high-purity water, uninterrupted power, and advanced materials.
- A severe shortage of specialized skilled talent in advanced semiconductor design and nano-fabrication.
- High capital intensity and long gestation periods demand sustained policy and financial commitment.
Way Forward
- Strengthening academia-industry linkages to bridge the specialized skill gap through dedicated curricula.
- Enhancing R&D funding for indigenous intellectual property and chip design startups.
- Fostering federal cooperation to streamline land acquisition, environmental clearances, and infrastructure delivery for fab units.
TRY THE DEMAND · ORIGINAL PRACTICE PROMPT
Examine the strategic imperatives and structural challenges facing India's ambition to become a global semiconductor manufacturing hub.
Generate a fresh timed question on this syllabus topic and build your own answer plan.
Practice this topic →Read the sources
News facts are drawn from these reports. The Mains analysis is our study interpretation.
How this theme has been asked
UPSC 2025 · GS 3
India aims to become a semiconductor manufacturing hub. What are the challenges faced by the semiconductor industry in India? Mention the salient features of the India Semiconductor Mission.
Read this PYQ →UPSC 2018 · GS 3
Examine the role of supermarkets in supply chain management of fruits, vegetables and food items. How do they eliminate number of intermediaries?
Read this PYQ →UPSC 2015 · GS 3
Success of ‘Make in India’ programme depends on the success of ‘Skill India’ programme and radical labour reforms. Discuss with logical arguments.
Read this PYQ →Make the next connection
GS 3 · Economy & agriculture
U.S. Tariff Waiver on Speciality Drugs and Implications for India’s Pharmaceutical Export Sector
On September 29, 2026, the United States announced a zero-percent tariff regime for specific categories of speciality drugs imported from 20 nations, including India. This policy adjustment targets life-saving pharmaceutical segments, including gene therapies, cell therapies, antibody-drug conjugates, rare disease medications, and infertility treatments. By removing tariff barriers for these complex medical products, the U.S. aims to diversify its pharmaceutical supply chains and lower costs for advanced healthcare. For India, the 'pharmacy of the world', this decision creates a significant incentive to transition beyond traditional generic manufacturing toward high-value biopharmaceuticals and complex medicinal components.